APPLIED BIOLOGY
Live / Applied — New application — not yet assigned to an examiner (as of 11 Sept 2026)
What this means for you
Not registered yet, but its 11 Sept 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50104124
- Mark type
- Word mark
- Filed
- 11 Sept 2026
- Attorney of record
- Muzamil Huq
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable computer software for using artificial intelligence for the analysis, integration, modeling, prediction, and simulation of genomic, multiomic, and clinical data for use in drug discovery and development, biomarker and therapeutic target identification, therapeutic response prediction, patient stratification, clinical trial design, precision medicine, and clinical research concerning human health and diseases
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software using artificial intelligence (AI) for the analysis, integration, modeling, prediction, and simulation of genomic, multiomic, and clinical data for use in drug discovery and development, biomarker and therapeutic target identification, therapeutic response prediction, patient stratification, clinical trial design, precision medicine, and clinical research concerning human health and diseases; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for the analysis, integration, modeling, prediction, and simulation of genomic, multiomic, and clinical data for use in drug discovery and development, biomarker and therapeutic target identification, therapeutic response prediction, patient stratification, clinical trial design, precision medicine, and clinical research concerning human health and diseases; Scientific research and development; Scientific and technological services, namely, scientific research, analysis, integration, modeling, prediction, and simulation in the field of immunology, pharmaceuticals, drug discovery, drug development, biomarker and therapeutic target identification, therapeutic response prediction, patient stratification, clinical trial design, precision medicine, clinical research, and human health and diseases
Owner
- Immunara Health, Inc., Dover, DE, US
Prosecution history
- 11 Sept 2026 — APPLICATION FILING RECEIPT MAILED
- 11 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Sept 2026 — NEW APPLICATION ENTERED